What does the nurse need to monitor for a client after administering Tenofovir/emtricitabine?

Monitoring kidney function is crucial after administering Tenofovir/emtricitabine, as this medication can potentially lead to renal toxicity. Tenofovir is known for its impact on the kidneys and can cause dose-dependent kidney injury, particularly in patients who may already have compromised renal function or who are taking other nephrotoxic medications. Regularly assessing parameters such as serum creatinine and electrolyte levels can help identify any issues early and allow for timely intervention.

In contrast, while blood glucose levels, liver function, and heart rate are important in the overall care of a client on antiretroviral therapy, they are not specifically indicated for monitoring with Tenofovir/emtricitabine. Blood glucose levels might be monitored if a patient has other risk factors for diabetes, liver function tests may be monitored due to the potential effects of other medications or comorbidities, and heart rate monitoring is typically related to factors such as cardiovascular status or medications that might affect cardiac function rather than a direct concern with this particular antiviral therapy.